Manufacturers Share Doubts About FDA’s ISO 13485 Audit Report Program
This article was originally published in The Gray Sheet
A voluntary new FDA program aims to relieve the inspectional load on manufacturers and the agency. But some device companies are skeptical that anyone will participate.
You may also be interested in...
After a decade of work, the Global Harmonization Task Force concludes its mission to align medical device regulations, but how far off is implementation?
FDA issues documents on advisory committee financial conflicts and scientific integrity. More regulatory updates.
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.